在翻译中发现：人类相当于鼠 CD8+树突状细胞。
Found in translation: the human equivalent of mouse CD8+ dendritic cells.
机构信息
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia.
出版信息
J Exp Med. 2010 Jun 7;207(6):1131-4. doi: 10.1084/jem.20100985. Epub 2010 May 31.
Abstract
The murine dendritic cell network comprises multiple subsets with distinct functions, but few of their human counterparts have been described. New data now reveals the likely human equivalent of the mouse DC subset specialized in cross-presentation.
摘要
鼠类树突状细胞网络由多个具有不同功能的亚群组成，但人类对应的亚群却很少被描述。现在的新数据揭示了可能与专门进行交叉呈递的小鼠 DC 亚群相当的人类细胞。
相似文献
1
Found in translation: the human equivalent of mouse CD8+ dendritic cells.在翻译中发现：人类相当于鼠 CD8+树突状细胞。
J Exp Med. 2010 Jun 7;207(6):1131-4. doi: 10.1084/jem.20100985. Epub 2010 May 31.
2
Effective Priming of Herpes Simplex Virus-Specific CD8 T Cells Does Not Require Infected Dendritic Cells.单纯疱疹病毒特异性CD8 T细胞的有效启动不需要受感染的树突状细胞。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01508-17. Print 2018 Feb 1.
3
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells.XC 趋化因子受体 1 是一种保守的选择性哺乳动物细胞标记物，与小鼠 CD8α+树突状细胞同源。
J Exp Med. 2010 Jun 7;207(6):1283-92. doi: 10.1084/jem.20100223. Epub 2010 May 17.
4
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.CLEC12A介导的人类树突状细胞亚群的抗原摄取和交叉呈递可有效增强肿瘤反应性T细胞应答。
J Immunol. 2016 Oct 1;197(7):2715-25. doi: 10.4049/jimmunol.1600011. Epub 2016 Aug 26.
5
Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.疫苗载体编码的腺病毒血清 5 型抗原，通过 CD8α+树突状细胞亚群，优先呈递给 CD8+T 淋巴细胞。
Vaccine. 2011 Aug 11;29(35):5892-903. doi: 10.1016/j.vaccine.2011.06.071. Epub 2011 Jul 1.
6
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.高抗原交叉呈递和 XCR1 表达将人 CD11c+CD141+ 细胞定义为小鼠 CD8+树突状细胞的同源物。
J Exp Med. 2010 Jun 7;207(6):1273-81. doi: 10.1084/jem.20100348. Epub 2010 May 17.
7
Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.尽管人浆细胞样树突状细胞对外源抗原的摄取低于髓系树突状细胞亚群，但仍能有效地将其交叉呈递给 CD8+ T 细胞。
Blood. 2013 Jan 17;121(3):459-67. doi: 10.1182/blood-2012-06-435644. Epub 2012 Dec 4.
8
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.人 CD141+（BDCA-3）+树突状细胞（DCs）代表了一种独特的髓样 DC 亚群，能够交叉呈递坏死细胞抗原。
J Exp Med. 2010 Jun 7;207(6):1247-60. doi: 10.1084/jem.20092140. Epub 2010 May 17.
9
Origin, precursors and differentiation of mouse dendritic cells.小鼠树突状细胞的起源、前体细胞及分化
Nat Rev Immunol. 2003 Jul;3(7):582-90. doi: 10.1038/nri1127.
10
CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.CD8⁻树突状细胞优先交叉提呈酿酒酵母抗原。
Eur J Immunol. 2008 Feb;38(2):370-80. doi: 10.1002/eji.200737647.
引用本文的文献
1
Overview of dendritic cells subsets and their involvement in immune-related pathological disease.树突状细胞亚群概述及其在免疫相关病理疾病中的作用
Bioimpacts. 2025 Jan 29;15:30671. doi: 10.34172/bi.30671. eCollection 2025.
2
Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors.基于树突状细胞的免疫治疗在热肿瘤和冷肿瘤中的应用。
Int J Mol Sci. 2022 Jun 30;23(13):7325. doi: 10.3390/ijms23137325.
3
Intratumoral cancer immunotherapy exploiting anti-viral immunity.利用抗病毒免疫的肿瘤内癌症免疫疗法。
J Clin Exp Hematop. 2022 Mar 9;62(1):1-8. doi: 10.3960/jslrt.21023. Epub 2021 Oct 26.
4
Differentiation of Human Induced Pluripotent Stem Cells (iPS Cells) and Embryonic Stem Cells (ES Cells) into Dendritic Cell (DC) Subsets.人类诱导多能干细胞（iPS细胞）和胚胎干细胞（ES细胞）向树突状细胞（DC）亚群的分化
Bio Protoc. 2017 Aug 5;7(15):e2419. doi: 10.21769/BioProtoc.2419.
5
Development of an Inflammatory CD14 Dendritic Cell Subset in Humanized Mice.在人源化小鼠中炎症性 CD14+ 树突状细胞亚群的发展。
Front Immunol. 2021 Mar 15;12:643040. doi: 10.3389/fimmu.2021.643040. eCollection 2021.
6
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.利用肿瘤微环境中cDC1与自然杀伤细胞的相互作用来对抗癌症。
Front Immunol. 2021 Feb 19;11:631713. doi: 10.3389/fimmu.2020.631713. eCollection 2020.
7
Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine.流感病毒感染新生儿的挑战和有效疫苗的前景。
Front Immunol. 2020 Sep 16;11:568651. doi: 10.3389/fimmu.2020.568651. eCollection 2020.
8
Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy.接触抗菌肽LL-37可产生经优化用于免疫治疗的树突状细胞。
Oncoimmunology. 2019 May 1;8(8):1608106. doi: 10.1080/2162402X.2019.1608106. eCollection 2019.
9
LangerinCD8 Dendritic Cells in the Splenic Marginal Zone: Not So Marginal After All.朗格汉斯细胞 CD8+ 树突状细胞在脾脏边缘区：并非如此边缘化。
Front Immunol. 2019 Apr 12;10:741. doi: 10.3389/fimmu.2019.00741. eCollection 2019.
10
In vivo cancer vaccination: Which dendritic cells to target and how?体内癌症疫苗接种：针对哪种树突状细胞，以及如何接种？
Cancer Treat Rev. 2018 Dec;71:88-101. doi: 10.1016/j.ctrv.2018.10.012. Epub 2018 Oct 25.
本文引用的文献
1
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells.XC 趋化因子受体 1 是一种保守的选择性哺乳动物细胞标记物，与小鼠 CD8α+树突状细胞同源。
J Exp Med. 2010 Jun 7;207(6):1283-92. doi: 10.1084/jem.20100223. Epub 2010 May 17.
2
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.鉴定人 DNGR-1+BDCA3+ 白细胞为鼠 CD8alpha+ 树突状细胞的假定同系物。
J Exp Med. 2010 Jun 7;207(6):1261-71. doi: 10.1084/jem.20092618. Epub 2010 May 17.
3
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.人 CD141+（BDCA-3）+树突状细胞（DCs）代表了一种独特的髓样 DC 亚群，能够交叉呈递坏死细胞抗原。
J Exp Med. 2010 Jun 7;207(6):1247-60. doi: 10.1084/jem.20092140. Epub 2010 May 17.
4
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.高抗原交叉呈递和 XCR1 表达将人 CD11c+CD141+ 细胞定义为小鼠 CD8+树突状细胞的同源物。
J Exp Med. 2010 Jun 7;207(6):1273-81. doi: 10.1084/jem.20100348. Epub 2010 May 17.
5
Differential expression of pathogen-recognition molecules between dendritic cell subsets revealed by plasma membrane proteomic analysis.通过质膜蛋白质组学分析揭示树突状细胞亚群之间病原体识别分子的差异表达。
Mol Immunol. 2010 May;47(9):1765-73. doi: 10.1016/j.molimm.2010.02.028. Epub 2010 Mar 29.
6
The CD8+ dendritic cell subset.CD8+ 树突状细胞亚群。
Immunol Rev. 2010 Mar;234(1):18-31. doi: 10.1111/j.0105-2896.2009.00870.x.
7
Quantitative proteomics reveals subset-specific viral recognition in dendritic cells.定量蛋白质组学揭示树突状细胞中特定亚群的病毒识别。
Immunity. 2010 Feb 26;32(2):279-89. doi: 10.1016/j.immuni.2010.01.013. Epub 2010 Feb 18.
8
Different cross-presentation pathways in steady-state and inflammatory dendritic cells.稳态和炎症状态下树突状细胞的不同交叉呈递途径。
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20377-81. doi: 10.1073/pnas.0910295106. Epub 2009 Nov 16.
9
Dendritic cell subsets in primary and secondary T cell responses at body surfaces.体表初次和二次T细胞应答中的树突状细胞亚群。
Nat Immunol. 2009 Dec;10(12):1237-44. doi: 10.1038/ni.1822. Epub 2009 Nov 16.
10
Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.趋化因子受体XCR1在交叉呈递树突状细胞上的选择性表达决定了与CD8 + T细胞的协同作用。
Immunity. 2009 Nov 20;31(5):823-33. doi: 10.1016/j.immuni.2009.08.027. Epub 2009 Nov 12.
Zotero 插件